Phrutsamon Wongnak

The authors have declared no competing interest. NCT05041907 Finding treatments for COVID-19: A phase 2 multi-centre adaptive platform trial to assess antiviral pharmacodynamics in early symptomatic COVID-19 (PLAT-COV) is supported by the Wellcome Trust Grant ref: 223195/Z/21/Z through the COVID-19 Therapeutics Accelerator. I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

A stochastic modelling study of quarantine strategies against foot-and-mouth disease risks through cattle trades across the Thailand-Myanmar border Mots clés cattle trade foot-and-mouth disease quarantine risk transboundary cattle trade foot-and-mouth disease quarantine risk transboundary Fichier principal 1-s2.0-S0167587724001685-main.pdf (835.61 Ko) Télécharger le fichier

Research in context Evidence before this study Antiviral interventions can be assessed and compared using acceleration in the rate of viral clearance as a surrogate for clinical benefit. We searched PubMed for studies published in English from Jan 1, 2020, to Jan 3, 2024, using the terms: (SARS-CoV-2) AND (randomised) AND (antiviral) AND (viral clearance OR viral kinetics).